-
Je něco špatně v tomto záznamu ?
In vitro study of interaction of 17β-hydroxysteroid dehydrogenase type 10 and cyclophilin D and its potential implications for Alzheimer's disease
E. Hemmerová, T. Špringer, Z. Krištofiková, J. Homola,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV16-27611A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01 do 2019-12-31
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01 do 2019-12-31
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
Springer Nature - nature.com Journals - Fully Open Access
od 2011-12-01
- MeSH
- 17-hydroxysteroidní dehydrogenasy metabolismus MeSH
- Alzheimerova nemoc metabolismus patologie MeSH
- amyloidní beta-protein metabolismus MeSH
- lidé MeSH
- mitochondrie metabolismus MeSH
- peptidylprolylisomerasa F metabolismus MeSH
- přechodový pór mitochondriální permeability MeSH
- techniky in vitro MeSH
- transportní proteiny mitochondriální membrány metabolismus MeSH
- vápník metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
In early stages of Alzheimer's disease (AD), amyloid-β (Aβ) accumulates in neuronal mitochondria where it interacts with a number of biomolecules including 17beta-hydroxysteroide dehydrogenase 10 (17β-HSD10) and cyclophilin D (cypD). It has been hypothesized that 17β-HSD10 interacts with cypD preventing it from opening mitochondrial permeability transition pores and that its regulation during AD may be affected by the accumulation of Aβ. In this work, we demonstrate for the first time that 17β-HSD10 and cypD form a stable complex in vitro. Furthermore, we show that factors, such as pH, ionic environment and the presence of Aβ, affect the ability of 17β-HSD10 to bind cypD. We demonstrate that K+ and Mg2+ ions present at low levels may facilitate this binding. We also show that different fragments of Aβ (Aβ1-40 and Aβ1-42) affect the interaction between 17β-HSD10 and cypD differently and that Aβ1-42 (in contrast to Aβ1-40) is capable of simultaneously binding both 17β-HSD10 and cypD in a tri-complex.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028753
- 003
- CZ-PrNML
- 005
- 20220221100035.0
- 007
- ta
- 008
- 210105s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-019-53157-7 $2 doi
- 035 __
- $a (PubMed)31723183
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hemmerová, Erika, $u Institute of Photonics and Electronics of the Czech Academy of Sciences, Chaberská 57, 182 51, Prague, Czech Republic. $d 1991- $7 xx0269692
- 245 10
- $a In vitro study of interaction of 17β-hydroxysteroid dehydrogenase type 10 and cyclophilin D and its potential implications for Alzheimer's disease / $c E. Hemmerová, T. Špringer, Z. Krištofiková, J. Homola,
- 520 9_
- $a In early stages of Alzheimer's disease (AD), amyloid-β (Aβ) accumulates in neuronal mitochondria where it interacts with a number of biomolecules including 17beta-hydroxysteroide dehydrogenase 10 (17β-HSD10) and cyclophilin D (cypD). It has been hypothesized that 17β-HSD10 interacts with cypD preventing it from opening mitochondrial permeability transition pores and that its regulation during AD may be affected by the accumulation of Aβ. In this work, we demonstrate for the first time that 17β-HSD10 and cypD form a stable complex in vitro. Furthermore, we show that factors, such as pH, ionic environment and the presence of Aβ, affect the ability of 17β-HSD10 to bind cypD. We demonstrate that K+ and Mg2+ ions present at low levels may facilitate this binding. We also show that different fragments of Aβ (Aβ1-40 and Aβ1-42) affect the interaction between 17β-HSD10 and cypD differently and that Aβ1-42 (in contrast to Aβ1-40) is capable of simultaneously binding both 17β-HSD10 and cypD in a tri-complex.
- 650 _2
- $a 17-hydroxysteroidní dehydrogenasy $x metabolismus $7 D015067
- 650 _2
- $a Alzheimerova nemoc $x metabolismus $x patologie $7 D000544
- 650 _2
- $a amyloidní beta-protein $x metabolismus $7 D016229
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a peptidylprolylisomerasa F $x metabolismus $7 D000081406
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a mitochondrie $x metabolismus $7 D008928
- 650 _2
- $a transportní proteiny mitochondriální membrány $x metabolismus $7 D033681
- 650 _2
- $a přechodový pór mitochondriální permeability $7 D000083162
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Špringer, Tomáš $u Institute of Photonics and Electronics of the Czech Academy of Sciences, Chaberská 57, 182 51, Prague, Czech Republic.
- 700 1_
- $a Krištofiková, Zdenka $u National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
- 700 1_
- $a Homola, Jiří $u Institute of Photonics and Electronics of the Czech Academy of Sciences, Chaberská 57, 182 51, Prague, Czech Republic. homola@ufe.cz.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 16700
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31723183 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20220221100033 $b ABA008
- 999 __
- $a ok $b bmc $g 1609088 $s 1119933
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 9 $c 1 $d 16700 $e 20191113 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- GRA __
- $a NV16-27611A $p MZ0
- LZP __
- $a Pubmed-20210105